PET PET
  • My Account
  • Subscribe
Become a Friend Donate
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • My Account
  • Subscribe
  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements
PETBioNewsNewsMedical Research Council spends £7 million on new genetics research equipment

BioNews

Medical Research Council spends £7 million on new genetics research equipment

Published 9 June 2009 posted in News and appears in BioNews 508

Author

Dr Will Fletcher

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.

The UK's Medical Research Council (MRC) has given three regional 'genetics hubs' over £7 million in funding so they can purchase the latest cutting-edge equipment which can read large amounts of DNA quickly, cheaply and accurately. The high-throughput sequencing (HTS) hubs will be created in Scotland, and...

The UK's Medical Research Council (MRC) has given three regional 'genetics hubs' over £7 million in funding so they can purchase the latest cutting-edge equipment which can read large amounts of DNA quickly, cheaply and accurately. The high-throughput sequencing (HTS) hubs will be created in Scotland, and the North and East of England, enabling the UK to retain its world-leading status in DNA research. This will have important implications for medical research including the possibility of speeding up bone marrow and organ transplants, and improving the diagnosis and treatment of many diseases.


The three hubs will give clinicians and medical researchers unprecedented access to the latest methods of reading the human genome and should yield fresh insights into how health is influenced by DNA, whilst enabling the delivery of better patient care. One of the first groups to benefit from the MRC investment could be transplant patients - a new project will investigate how they can be matched to suitable donors more quickly and accurately through the use of genetic sequencing. There are also plans to explore the technology's potential for pre-natal diagnosis of Down syndrome, and to identify the inherited genetic mutations that can cause kidney and eye disorders, and colon and breast cancer.


Mark Blaxter, from the University of Edinburgh and Principal Investigator of the Scotland Hub, said: 'This investment from the MRC will allow us to support and underpin world-leading genetics research across Scotland and beyond, working with MRC researchers investigating issues such as familial cancers, psychiatric disease and the genomics of pathogens such as E. coli, C. difficile and malaria.'


The Northern hub, based in Liverpool, will enhance the facilities already available to researchers through the Advanced Genomics Facility. Professor Neil Hall, from the University of Liverpool and Principal Investigator of the North of England Hub, said that 'there is a pressing need to understand the basis of genetic variation and to use it to define the most appropriate treatment for each patient with a particular condition'. He added: 'This personalised medicine will require establishing the DNA sequence of particular genes in those patients. Such research will benefit greatly from the new HTS hub.'


Professor John Todd, from Cambridge University and the third Principal Investigator, explained: 'Only a few years ago, it took an international consortium many years of effort to produce a first draft of the human genome sequence, but now it will be possible for the proposed hub in Cambridge, the Eastern Sequence and Informatics Hub (EASIH), to re-sequence 100 human genomes in a year.' EASIH will be based at Addenbrooke's Hospital in Cambridge and plans to collaborate with the National Blood Service and the NHS Regional Clinical Genetics Services, with the strategic aim of applying HTS to routine medical diagnostic uses.

Related Articles

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
28 March 2013 • 1 minute read

Scottish genetics institute receives £60 million funding boost

by Dr Lux Fatimathas

The Medical Research Council has awarded £60 million to the University of Edinburgh to advance research into human genetic diseases...

PET BioNews
News
22 October 2010 • 1 minute read

UK immigration policy is affecting scientific research, experts claim

by Owen Clark

One of Britain's leading research institutes has warned that it will struggle to recruit top scientists due to new visa restrictions....

Leave a Reply Cancel reply

You must be logged in to post a comment.

« Genes identified that influence gambling patterns and anger management

Data-Label The UK's Leading Supplier Of Medical Labels & Asset Labels

RetiringDentist.co.uk The UK's Leading M&A Company.
easyfundraising
amazon

This month in BioNews

  • Popular
  • Recent
13 June 2022 • 2 minutes read

Drop in diversity of blood stem cells leads to old-age health issues

5 July 2022 • 1 minute read

No difference between fresh and frozen sperm for IUI

4 July 2022 • 2 minutes read

Shorter IVF protocol reduces risk of OHSS

4 July 2022 • 2 minutes read

USA scrambles to understand implications of Roe v Wade on fertility industry

4 July 2022 • 2 minutes read

Genetic and epigenetic causes of IVF embryo arrest discovered

4 July 2022 • 2 minutes read

Dutch donor-conceived people seek answers

Subscribe to BioNews and other PET updates for free.

Subscribe
  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856

Subscribe to BioNews and other PET updates for free.

Subscribe
PET PET

PET is an independent charity that improves choices for people affected by infertility and genetic conditions.

  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Navigation

  • About Us
  • Get Involved
  • Donate
  • BioNews
  • Events
  • Engagement
  • Jobs & Opportunities
  • Contact Us

BioNews

  • News
  • Comment
  • Reviews
  • Elsewhere
  • Topics
  • Glossary
  • Newsletters

Other

  • My Account
  • Subscribe

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856